| RS2056117839 |
UPF3B
|
Health Risk |
Pathogenic |
— |
| RS2056118338 |
SETD1A
|
Health Risk |
Pathogenic |
Epilepsy, early-onset |
| RS2056119926 |
UPF3B
|
Health Risk |
Likely pathogenic |
Intellectual disability, Syndromic X-linked intellectual disability 14 |
| RS2056124989 |
SETD1A
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with speech impairment and dysmorphic facies, Neurodevelopmental disorder with speech impairment and dysmorphic facies |
| RS2056139851 |
SETD1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with speech impairment and dysmorphic facies, Neurodevelopmental disorder with speech impairment and dysmorphic facies |
| RS2056144779 |
SETD1A
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS2056158149 |
SETD1A
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with speech impairment and dysmorphic facies, Epilepsy |
| RS2056165149 |
SETD1A
|
Health Risk |
Likely pathogenic |
Epilepsy, early-onset |
| RS2056190516 |
ARHGAP35
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2056193902 |
CACNA1A
|
Health Risk |
Likely pathogenic |
— |
| RS2056249919 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2056279996 |
TCF4
|
Health Risk |
Pathogenic |
— |
| RS2056303175 |
DOCK8
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to DOCK8 deficiency, Combined immunodeficiency due to DOCK8 deficiency |
| RS2056308423 |
TCF4
|
Health Risk |
Pathogenic |
— |
| RS2056315077 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2056319448 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Ventricular tachycardia |
| RS2056330918 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2056360507 |
SETD1A
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with speech impairment and dysmorphic facies, Neurodevelopmental disorder with speech impairment and dysmorphic facies |
| RS2056362368 |
ANKRD26
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2056406264 |
RNF113A
|
Health Risk |
Pathogenic |
Trichothiodystrophy 5, nonphotosensitive |
| RS2056442109 |
TRIP11
|
Health Risk |
Pathogenic |
Achondrogenesis, type IA |
| RS2056443833 |
CACNA1A
|
Health Risk |
Pathogenic |
— |
| RS2056447170 |
TRIP11
|
Health Risk |
Pathogenic |
Achondrogenesis, type IA |
| RS2056449254 |
TRIP11
|
Health Risk |
Likely pathogenic |
Achondrogenesis, type IA |
| RS2056451263 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2056452818 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 |
| RS2056453893 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2056453972 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2056458051 |
RUNX1
|
Health Risk |
Likely pathogenic |
Myelodysplasia, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2056470234 |
HSD3B7
|
Health Risk |
Likely pathogenic |
Congenital bile acid synthesis defect 1, Congenital bile acid synthesis defect 1 |
| RS2056504499 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2056510928 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2056551129 |
KIF1A
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 9 |
| RS2056552812 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Neuropathy |
| RS2056558371 |
KIF1A
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 9 |
| RS2056562900 |
KIF1A
|
Health Risk |
Pathogenic |
Neuropathy, hereditary sensory |
| RS2056572481 |
STX1B
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2056573081 |
STX1B
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 9 |
| RS2056573240 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2056574456 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Inborn genetic diseases |
| RS2056577059 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2056578041 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2056581815 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2056596353 |
STX1B
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 9 |
| RS2056596896 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2056599363 |
ANKRD26
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2056600391 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Episodic ataxia type 2 |
| RS2056602254 |
CACNA1A
|
Health Risk |
Pathogenic |
— |
| RS2056602306 |
CACNA1A
|
Health Risk |
Pathogenic |
— |
| RS2056602388 |
STX1B
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 9 |
| RS2056613965 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2056619632 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2056624422 |
STX1B
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 9 |
| RS2056625682 |
STX1B
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 9 |
| RS2056626672 |
STX1B
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 9 |
| RS2056640828 |
DOCK8
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to DOCK8 deficiency, Combined immunodeficiency due to DOCK8 deficiency |
| RS2056668331 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Dilated cardiomyopathy 1G |
| RS2056674737 |
CACNA1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS2056711749 |
BRF1
|
Health Risk |
Likely pathogenic |
— |
| RS2056733058 |
CACNA1A
|
Health Risk |
Pathogenic |
— |
| RS2056733130 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2056766498 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2056767062 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 42 |
| RS2056767185 |
NEUROD2
|
Health Risk |
Likely pathogenic |
— |
| RS2056767982 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 42 |
| RS2056768058 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Migraine, familial hemiplegic |
| RS2056812732 |
ADAMTS18
|
Health Risk |
Pathogenic |
— |
| RS2056816939 |
MYT1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, Inborn genetic diseases |
| RS2056843518 |
MYT1L
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 39 |
| RS2056846558 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2056867686 |
LOC126806426;TTN;TTN-AS1
|
Health Risk |
Likely pathogenic |
— |
| RS2056871742 |
TRIP11
|
Health Risk |
Pathogenic |
Achondrogenesis, type IA |
| RS2056901001 |
TRIP11
|
Health Risk |
Pathogenic |
Connective tissue disorder, Connective tissue disorder |
| RS2057009434 |
TRIP11
|
Health Risk |
Likely pathogenic |
Connective tissue disorder, Connective tissue disorder |
| RS2057015875 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2057017245 |
TCF12
|
Health Risk |
Likely pathogenic |
— |
| RS2057026455 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2057028176 |
TRIP11
|
Health Risk |
Pathogenic |
Achondrogenesis, type IA |
| RS2057088963 |
DOCK8
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to DOCK8 deficiency, Combined immunodeficiency due to DOCK8 deficiency |
| RS2057094 |
PADI2
|
Health Risk |
association |
Rheumatoid arthritis, Abnormal pulmonary interstitial morphology |
| RS2057097206 |
TCF4
|
Health Risk |
Pathogenic |
— |
| RS2057107899 |
DOCK8
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to DOCK8 deficiency, Combined immunodeficiency due to DOCK8 deficiency |
| RS2057114964 |
TRIP11
|
Health Risk |
Likely pathogenic |
Achondrogenesis, type IA |
| RS2057135958 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2057136334 |
CACNA1A
|
Health Risk |
Pathogenic |
— |
| RS2057168559 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS2057189303 |
GRIP1
|
Health Risk |
Pathogenic |
Fraser syndrome 3, Fraser syndrome 3 |
| RS2057249899 |
TCAP
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 25, Primary familial hypertrophic cardiomyopathy |
| RS2057250066 |
TCAP
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 25, Primary familial hypertrophic cardiomyopathy |
| RS2057353041 |
PGAP3
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 4, Hyperphosphatasia with intellectual disability syndrome 4 |
| RS2057353122 |
PGAP3
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 4, Hyperphosphatasia with intellectual disability syndrome 4 |
| RS2057367803 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2057370325 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Dilated cardiomyopathy 1G |
| RS2057372365 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Migraine, familial hemiplegic |
| RS2057373332 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2057392733 |
BCKDK
|
Health Risk |
Pathogenic |
Branched-chain keto acid dehydrogenase kinase deficiency, Branched-chain keto acid dehydrogenase kinase deficiency |
| RS2057404166 |
BCKDK
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS2057404615 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2057404744 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS2057418362 |
DCC
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |